Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Human Genome 2020

About Conference

Human Genome 2020 takes great pleasure and feels esteemed in welcoming the contributors over the globe to attend “13th World Conference on Human Genomics and Genomic Medicine” during August 10-11, 2020 going to be held in  Dubai, UAE which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

The theme of this Conference is “New Strategies and Emerging Trends in Human Genome and Genomic Medicine”, which means just not to learn but also to explore the different discoveries which are evolving in the genetic field . It will also benefit to find the new practises in the field which will be beneficial for humans as well as environment. 

Human Genomics and Genomic Medicine encompass a variety of fields including: classical genetics, cytogenetic, molecular genetics, biochemical genetics, genomics, population genetics, developmental genetics, clinical genetics, and genetic counselling an emerging medical discipline that involves using genomic information about an distinct as part of their medical and the healthiness outcomes and policy suggestions of that clinical use." Already, genomic medicine is newest trend in the fields of oncology, pharmacology, rare and undiagnosed diseases, and infectious disease.

Why to attend?

With members from around the world focused on learning about Human Genomics & Genomic Medicine and its advances; this is could be your greatest opportunity  to reach one of the largest assemblage of participants from the Genomics and its allied areas. Present research, share information, meet with current and potential scientists, make a mark with new drug developments, and receive name recognition at this 2-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Genomics & Pharmaco Genomics, Gene Therapy, Oncogenomics, Epigenetics, Genetic Testing, Immuno Genomics, and Clinical Genomics are hallmarks of this conference.

Target Audience 

  • Bio pharmacist
  • Biotechnologists 
  • Business Entrepreneurs
  • Gene Therapy Researchers, Scientists and Students
  • Genetic Counsellors
  • Genetic Engineers
  • Geneticists
  • Genetics Associations and Societies
  • Genomics Colleges
  • Genomics Faculty
  • Genomics Researchers
  • Genomics Scientists
  • Immunologists
  • Molecular Researchers
  • Oncologist
  • Pharmacology Health Professionals
  • Pharmacology Scientists
  • Plant Genomics Students, Scientists

Sessions / Tracks

Track 01: Genomics

Genomics is an interdisciplinary field of science concentrating on the structure, work, progress, mapping, and adjusting of genomes. A genome is a life structure's entire plan of DNA, including the vast majority of its qualities. Rather than inborn qualities, which hints the assessment of individual attributes and their parts in legacy, genomics goes for the all-out delineation and evaluation of qualities, which orchestrate the period of proteins with the help of blends and clergyman particles

Track 02: Human Genetics

Human hereditary qualities are the investigation of legacy as it happens in people. Qualities are the normal factor of the characteristics of most human-acquired characteristics. Investigation of human hereditary qualities can respond to inquiries regarding human instinct, can help get disease and the advancement of compelling ailment treatment, and help us to

 Track 03 :  Genetic Disorders

Genetic disorders might be hereditary, passed down from the guardians qualities. In other inborn issue, blemishes might be achieved by new changes or changes to the DNA. Hereditary disorders can be brought about by a change in monogenic disorder, by transformations in multifactorial legacy issue, by a blend of quality transformations and natural factors, or by harm to chromosomes Some sicknesses are brought about by transformations that are acquired from the guardians and are available in a person during childbirth, similar to sickle cell illness.

 Track 04: Genetic Testing

Genetic Testing is a kind of restorative test that distinguishes changes in chromosomes, qualities, or proteins. The consequences of a genetic test can affirm or prevent a presumed hereditary condition or help decide an individual's possibility of passing on a hereditary disease. Since testing has benefits just as impediments and dangers, the choice about whether to be tried is an individual and complex one.

 Track 05 : Gene Therapy

Gene Therapy is a trial procedure that utilizations qualities to treat or prevent disease. Specialists are trying a few ways to deal with quality treatment, including:

  • Replacing a changed quality that causes sickness with a solid duplicate of the quality.
  • Inactivating, or "taking out," a changed quality that is working inappropriately.
  • Introducing another quality into the body to help battle an illness

 If a mutated gene that makes a vital protein be flawed or missing, gene therapy might have the option to present a typical duplicate of the gene to re-establish the capacity of the protein. Rather, a bearer called a vector is hereditarily designed to convey the quality. Certain infections are frequently utilized as vectors since they can convey the new quality by tainting the cell. The infections are altered so they can't cause illness when utilized in individuals.

 Track 06 : Clinical genomics

Clinical genomics is the investigation of clinical results with genomic information. Genomic factors causally affect clinical information. Clinical genomics utilizes the whole genome of a patient so as to analyse maladies or modify meds only for that patient. Entire genome testing can distinguish a larger number of changes and basic inconsistencies than focused quality testing. Furthermore, directed quality testing can test for the infections for which the specialist screens, while testing the entire genome screens for all diseases with known markers at once. By concentrating the entire genome, a doctor can develop therapeutic plans dependent on an individual patient's genome

Track 07: Pharmacogenomics

Pharmacogenomics is the investigation of the job of the genome in medicates reaction. Its name mirrors its joining of pharmacology and genomics. Pharmacogenomics breaks down how the hereditary cosmetics of an individual influences his/her reaction to drugs manages the impact of gained and acquired hereditary minor departure from medicate reaction in patients by relating quality articulation or single-nucleotide polymorphisms with pharmacokinetics and pharmacodynamics term pharmacogenomics is regularly utilized reciprocally with pharmacogenomics

 Track 08 : Immunogenomics

Immunogenetics is under a division of therapeutic hereditary qualities that endeavors the connection between the hereditary qualities and the resistant framework. Type 1 diabetes is an Auto immune sickness; it has complex hereditary characteristics which result because of imperfections in the safe framework. New target qualities for remedial methodologies are distinguished by Identification of qualities characterizing the resistant deficiencies. On the other hand, by utilizing hereditary variety the immunological pathway prompting infection is characterized. It features the developing specialized and different theoretical leaps forward that pitch for systems of hostile to benefactor reactions.

 Track 09: Single Cell Genomics

Advances in entire genome and entire transcriptome intensification have allowed the sequencing of the instant measures of DNA and RNA present in a lonely cell, offering a window into the degree and nature of genomic and transcriptome heterogeneity which happens in both ordinary improvement and disease. Single-cell approaches stand ready to reform our ability to comprehend the size of genomic, epigenetic, and transcriptome decent variety that happens during the lifetime of an individual creature. Here, we survey the major innovative and organic rises forward accomplished, portray the rest of the difficulties to survive, and give a look into the guarantee of later and future improvements.

 Track 10: Neuro Genomics

Neurogenetics is the part of hereditary qualities which examines the advancement and capacity of the sensory system. Numerous neurological issue like Alzheimer’s and Parkinson's sicknesses can be identified with neurogenesis and the examination of hereditary qualities on neurological issue are still on-going. Neurogenetics is developing as one field that may yield a causative association. The revelation of linkages could then prompt remedial medications, which could invert mind degeneration.

 Track 11 : Nutri Genomics

Nutritional genomics, otherwise called nutrigenomics, is a science concentrating the connection between human genome, nutrition and wellbeing. Individuals in the hands on work toward building up a comprehension of how the entire body reacts to a nourishment v, hereditary varieties influence the manner in which we respond to supplements in nourishments. Through the investigations of the human genome, specialists and researchers have found that various individuals react in various manners to various eating regimens in light of the fact that the varieties in our DNA can significantly affect our metabolic productivity, how or what makes us lose or put on weight and that's just the beginning.

Track 12: Behavioural Genetics

Behaviour genetic qualities are the investigation of hereditary and natural effects on practices. By looking at hereditary impact, more data can be gathered about how the earth works to influence conduct. Practically all practices contemplated by analysts are influenced by our hereditary cosmetics discoveries from social hereditary research have extensively affected the cutting edge comprehension of the job of hereditary and natural impacts on conduct. These incorporate proof that about all discovered practices are under a critical level of hereditary impact, and that impact will in general increment as people form into adulthood.

 Track 13 : Genomic Technologies

Genomic advances have had an immense affect crosswise over numerous fields, for example, medication, farming, bioenergy generation, manufactured science, ecological science, computational science, data innovation, and wellbeing and health the executives. The centre has quickly moved to cutting edge genome sequencing advancements from the regular research centre hereditary systems.

 Track 14 : Epigenetics

Epigenetics is the investigation of heritable phenotype changes that don't include modifications in the DNA sequence. Epigenetics regularly includes changes that influence quality movement and articulation, yet the term can likewise be utilized to depict any heritable phenotypic change. Such impacts on cell and physiological phenotypic attributes may result from outer or ecological factors, or be a piece of typical advancement. The standard meaning of epigenetics requires these modifications to be heritable. The term likewise alludes to the progressions themselves: practically pertinent changes to the genome that don't include an adjustment in the nucleotide arrangement

 Track 15: Oncogenomics

Oncogenomics is a sub-field of genomics that portrays malignant growth-related qualities. It centres on genomic, epigenetics and transcript changes in malignancy. Malignancy is a hereditary illness brought about by the gathering of DNA transformations and epigenetic modifications prompting unreasonable cell expansion and neoplasm arrangement. The objective of oncogenomics is to recognize new oncogenes or a tumour silencer quality that may give new bits of knowledge into malignant growth conclusion, foreseeing the clinical result of diseases and new focuses for disease treatments. The accomplishment of focused malignant growth treatments, for example, Gleevec, Herceptin and Avastin raised the expectation for oncogenomics to clarify new focuses for disease treatment

Track 16: Cytogenetic

Cytogenetic is a part of hereditary qualities that is worried about how the chromosomes identify with cell conduct, especially to their conduct during mitosis and meiosis. It has created throughout the years from the unrefined investigation of mitotic cells utilizing straightforward stains, to an examination of expanded DNA strands utilizing computerized fluorescence microscopy and picture examination hello have assumed a significant job in the check of quality request in such maps and have added to the push to succession the human genome.

Track 17: Medical Genetics

Medical Genetics qualities are the part of medication that includes the conclusion and the executives of innate issue. Restorative genetic qualities contrasts from qualities in that human hereditary qualities is a field of logical research that could conceivably apply to medication, while therapeutic hereditary qualities alludes to the utilization of hereditary qualities to medicinal consideration. Hereditary medication is a more up to date term for therapeutic hereditary qualities and joins territories, for example, quality treatment, customized prescription, and the quickly rising new restorative strength, prescient drug

Track 18: Microbial Genomics

Microbial hereditary qualities are a branch of knowledge inside microbiology and hereditary designing. Microbial hereditary qualities read microorganisms for various purposes. The microorganisms that are watched are microbes and Achaea. A few growths and protozoa are additional subjects used to contemplate in this field. The investigations of microorganisms include investigations of genotype and articulation framework. Genotypes are the acquired structures of a living being utilization of recombinant DNA innovation is a procedure of this work. The procedure includes making recombinant DNA atoms by controlling a DNA grouping. That DNA made is then in contact with a host living being. Cloning is additionally a case of hereditary designing.

Track 19:  Meta Genomics

Metagenomic is the study of genetic material recovered directly from environmental samples. The broad field may also be referred to as environmental genomics, economics or community genomics. Because of its ability to reveal the previously hidden diversity of microscopic life, metagenomic offers a powerful lens for viewing the microbial world that has the potential to revolutionize understanding of the entire living world. As the price of DNA sequencing continues to fall, metagenomic now allows microbial ecology to be investigated at a much greater scale and detail than before. Recent studies use either "shotgun" or PCR directed sequencing to get largely unbiased samples of all genes from all the members of the sampled communities



Market Analysis

The Growth of Human Genome Market over the years:

The worldwide genomics showcase size was evaluated at USD 15.48 billion out of 2018 and is foreseen to extend at a CAGR of 8.6% over the conjecture time frame. The development of genomic information pool due research exercises has empowered doctors, scholars, and patients to additionally examine the hereditary inclination to specific infections. Clinical use of this information pool is required to assume a significant job in changing the human services framework regarding the arrangement of increasingly exact, compelling, and dependable illness the board arrangements.

In spite of the fact that the clinical use of genomic information is at a beginning stage in present, the social insurance and research network are making endeavours for compelling reconciliation of hereditary data into clinical work processes. A few clinical focuses, for example, Stanford Health Care and other malignant growth investigate focuses, have started utilizing the accessible genomic data to devise customized treatment system. This, thusly, helps in crossing over any barrier between translational research and clinical determination and treatment. The worldwide hereditary testing market since 2015 and the market is ready to develop by USD 4.86 billion during 2020-2024 at a CAGR of over 12% during the conjecture time frame.

Market study of Human Genetics:

The Genetic Market is increasing day by day .Each Continents are having their share in the growing market of human genomics. The most contributed continent in this regard is Middle East which contributes about 31% and the second contributed country is Asia Pacific which contributes about 30%. Them it is followed by USA which con tributes only 22%in the market .The least contribution is made by Europe which is 17%only.

The future of Human Genome:

The worldwide market of human hereditary qualities holds the monstrous potential to flood. Qualities are the keys that open the complexities of how the body capacities, which can help in the advancement of better diagnostics and viable treatment for the lethal issue, for example, malignant growth and AIDs or clutters, for example, Alzheimer and Parkinson that have constrained treatment choices. The ascent deprived to meet the medicinal prerequisites of patients is required to provoke development for the overall human hereditary market. The development of the patient pool is probably going to reinforce the market. It is seen that the human hereditary market is probably going to blast in the coming years.

The ascent in awareness of quality treatment and increment in the commonness of quality treatment is noted to heighten the human hereditary qualities showcase development. Innovative work focuses and criminological labs are very good quality clients of the human hereditary qualities methods. Governments, over the globe, making robust speculations, and increment in wrongdoing cases are causes that are probably going to make the market pattern upwards. The ascent deprived for progressively compelling and non-intrusive treatment and urgent need to rapidly explain criminal cases are can enlarge the market development. Nonetheless, the absence of prepared experts can block the human hereditary qualities showcase development

List of Hospitals, Research Centers and Labs 

  • International Livestock Research Institute

  • Chinese National Human Genome Center

  • Institute of Molecular and Cell Biology

  • Columbus Community Hospital

  • National Center for Genome Resources

  • National Institute of Genetics

  • Philippine Genome Center

  • Genome Institute of Singapore

  • Mediclinic Al Noor Hospital

  • International Genetic Resources Institute

  • Mediclinic Welfare Hospital

  • Institute of Molecular Systems Biology

  • Folkhalsan Research Center

  • The Minerva Foundation Institute for Medical Research

  • Helsinki Finland Hospital

  • Helix

  • Genetic Technologies Group

  • GeneWorks

  • Ambry Genetics

  • Biospyder Technologies

  • Predictive biology

  • NeoGenomics

  • Cypher Genomics

  • Agena Bioscience

  • Gigagen

  • ValueGene 

List of National Human Genetic Societies

  • All-Ukranian Genetics Association Experts of Medical and Laboratory Genetics

  • Armenian Society of Human Genetics

  • Austrian Society of Human Genetics

  • Belgian Society of Human Genetics (BeSHG)

  • British Society of Genetic Medicine

  • Bulgarian Society of Human Genetics

  • Clinical Genetics Society of Croatia

  • Croatian Society of Human Genetics

  • Cyprus Society of Human Genetics

  • Czech Society of Medical Genetics

  • Danish Society of Medical Genetics

  • Dutch Society of Human Genetics

  • Dutch Society for Laboratory Specialist Clinical Genetics

  • Dutch Society of Clinical Genetics

  • Estonian Society of Human Genetics

  • Finnish Society of Medical Genetics

  • French Association of Genetic Counsellors (AFCG)

  • French Federation of Human Genetics

  • French Society of Human Genetics

  • Genetic Association in Bosnia and Herzegovina (Udruženje geneticara u BiH – GENUBIH)

  • Genetic Counselors of Belgium - GCBe

  • Genetics Society of Israel

  • Georgian Society of Medical Genetics and Epigenetics

  • German Society of Human Genetics

  • Hellenic Association of Medical Geneticists

  • Hungarian Society of Human Genetics

  • Icelandic Human Genetics Society

  • Irish Society of Human Genetics

  • Israeli Society of Medical Genetics

  • Italian Society of Human Genetics

  • Latvian Association of Human Genetics

  • Latvian Society of Medical Genetics

  • Lithuanian Association of Genetics

  • Lithuanian Society of Human Genetics

  • Macedonian Society of Human Genetics

  • Malta College of Pathologists, Human Genetics Group

  • Medical Genetics Society of Israel

  • National Board of Clinical Geneticists of Georgia

  • Norwegian Society of Human Genetics (NSHG)

  • Norwegian Society of Medical Genetics

  • Polish Society of Human Genetics

  • Portuguese Society of Human Genetics

  • Romanian Society of Human Genetics

  • Russian Society of Medical Genetics

  • Serbian Genetic Society, Section for Medical Genetics

  • Slovak Society of Medical Genetics

  • Slovenian Association of Medical Genetics

  • Slovenian Society of Human Genetics

  • Spanish Association of Human Genetics

  • Swiss Association of Genetic Counsellors

  • Swiss Society of Medical Genetics

  • The Swedish Society of Medical Genetics and Genomics (SFMG)

  • Turkish Society of Medical Genetics

Past Conference Report

Human Genome 2019

Human Genome 2019

12th World Congress on Human Genome and Genomic Medicine was hosted by ME Conferences during April 08-09, 2019 in Abu Dhabi, UAE on the theme “Discovery to Interpretation and Implementation” Active responses and great reviews are given by the Organizing Committee Member, the scientists and the young community students who came to attend the Conference from different parts of the world. The Conference marked the presence of renowned speakers, young researchers, business delegate, Students who made the Conference a most successful and productive event of 2019.

The conference marked its start by an opening ceremony which included introduction by the Honourable GuestDr. Mariam Fida, Al Jawhara Center, Bahrain.

We are very overwhelmed by her presence and her generous response.

Human Genome 2019 Organizing Committee extends its gratitude and congratulates the honourable moderators of the conference, Dr. Nigora Mavlyanova, Ministry of Health of the Republic of Uzbekistan, Uzbekistan and Dr. Salma Alyssa Ferouz, Guyana Cancer Foundation, Guyana for their preeminent contribution towards the smooth functioning of this esteemed event.

We have taken a privilege of felicitating our keynote Speakers:

  • Dr. Manohar Furtado | Apton Biosystems Inc. | USA
  • Dr. Vojin Rakić | Center for the Study of Bioethics- University of Belgrade | Serbia
  • Dr. Pravin Potdar  | Dr. A P J Abdul Kalam Education & Research Centre | India
  • Dr. Meena Upadhyaya  | Cardiff University | UK

Who shared their innovative researches and vast experience through their fabulous presentations during the event.

The eminent personalities at the conference were

•           Dr. Manohar Furtado  | Apton Biosystems Inc. | USA

•           Dr. Meena Upadhyaya | Cardiff University | UK

•           Dr. Pravin Potdar | Dr. A P J Abdul Kalam Education & Research Centre | India

•           Dr. Mariam Fida | Al Jawhara Center | Bahrain

 •          And many more

Exhibitor: EDgene, India

Last but not the least; we are obliged to various delegate experts, Company representatives, eminent personalities who supported the Conference by facilitating active discussion forums. We would like to convey our sincere gratitude to all the supporters from Editorial Board Members of our Open Access Journals, Keynote Speakers, Honourable guests, Valuable Speakers, Students, delegates and special thank s to Media Partners  for their promotions to make this event a successful one.

With the unique feedbacks from the Conference Human Genome 2019, we would like to announce the commencement of the 13th World Congress on Human Genome and Genomic Medicine  to be held during August 10-11, 2020 in Dubai, UAE.


Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date August 10-11, 2020

Speaker Opportunity

Supported By

Journal of Molecular and Genetic Medicine Journal of Pharmacogenomics & Pharmacoproteomics Journal of Human Genetics & Embryology Journal of Genetic Syndromes & Gene Therapy

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by